Behind me is
the CFC
lab, the latest innovation
that we're proud to launch here at Interpack.
This is a technology that we're excited about introducing
to the market for products
such as GLP-1 antagonists that are known to be soft, large and friable.
The CFC system
offers an opportunity to coat these types
of formulations and develop it quickly with relative ease.
Film coating hasn't changed much over the years,
but of course
the market around it
has: higher requirement for the speed to market, flexibility
in adapting to changing supply chains
and of course, higher drug load APIs,
resulting in soft and friable tablets or challenges
that R&D departments have to overcome, and also for generics or CDMOs,
multi-product facilities where hundreds of products are manufactured,
it is very difficult to accommodate with traditional batch
coating systems.
This motivated us to innovate and develop the CFC lab,
a product
that's aimed towards solving
a lot of these issues in the lab and R&D environment.
Borrowing from the continuous manufacturing philosophy, applying
a true scale out scaleless system,
transferring processes from
R&D scale to production scale with this technology is extremely easy.
Leveraging our unique coating principle,
challenging formulations such as soft and friable
tablets are able to be developed and produced within days and weeks.
One advantage is the ability to produce
a full design of experiments in one day.
So I invite you to come to one of our test centers,
bring your most challenging formulation, and we'll be happy to
try it out on the CFC lab.
